Treatment of myelofibrosis patients with the TGF-β 1/3 inhibitor AVID200 (MPN-RC 118) induces a profound effect on platelet production Meeting Abstract

  

Authors:	Mascarenhas, J.; Kosiorek, H. E.; Bhave, R.; Palmer, J. M.; Kuykendall, A. T.; Mesa, R. A.; Rampal, R.; Gerds, A. T.; Yacoub, A.; Pettit, K. M.; Talpaz, M.; Komrokji, R. S.; Kremyanskaya, M.; Gonzalez, A.; Fabris, F.; Sandy, L.; Johnson, K.; Doughtery, M.; McGovern, E.; Ossa, J. A.; Domenico, D.; Farnoud, N.; Migliaccio, A. R.; Salama, M. E.; Weinberg, R. S.; Kong, A.; Najfeld, V.; Mead-Harvey, C.; Dueck, A. C.; Varricchio, L.; Hoffman, R.
Abstract Title:	Treatment of myelofibrosis patients with the TGF-β 1/3 inhibitor AVID200 (MPN-RC 118) induces a profound effect on platelet production
Meeting Title:	63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	138
Issue:	Suppl. 1
Meeting Dates:	2021 Dec 11-14
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2021-11-23
Language:	English
ACCESSION:	WOS:000736398800140
DOI:	10.1182/blood-2021-148995
PROVIDER:	wos
Notes:	Meeting Abstract: 142 -- Hybrid meeting, also took place online -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/198873